PaulRSieberMD

PubMed

• Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Prog...
  Wassim Abida, Andrew W Hahn, Neal Shore, Neeraj Agarwal, Paul Sieber, Matthew R Smith, Tanya Dorff, Paul Monk, Matthew Rettig, Rupal Patel, Anne Page, Maureen Duff, Ro...> ;Clinical Cancer Research. 2024 Mar 15
• 2 citations
  Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer.
  Benjamin Lowentritt, Gordon Brown, Dominic Pilon, Lorie Ellis, Guillaume Germain, Carmine Rossi, Patrick Lefebvre, Kenneth Kernen, Paul Sieber, Neal Shore> ;Urology. 2022 Aug 1
• 10 citations
  Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
  Christopher J Sweeney, Ivor J Percent, Sunil Babu, Jennifer L Cultrera, Bryan A Mehlhaff, Oscar B Goodman, David S Morris, Ian D Schnadig, Costantine Albany, Neal D Sh...> ;Clinical Cancer Research. 2022 Jun 1
• 8 citations
  Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians
  Neal D. Shore, Charles G. Drake, Daniel W. Lin, Charles J. Ryan, Kelly L. Stratton, Curtis Dunshee, Lawrence Karsh, Sanjeev Kaul, Ken Kernen, Christopher Michael Piecz...> ;The Prostate. 2020 Aug 11
• 16 citations
  Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
  John L. Gore, Marguerite du Plessis, Jingbin Zhang, Darlene L.Y. Dai, Darby J. S. Thompson, Lawrence Karsh, Brian R. Lane, Michael E. Franks, David Y.T. Chen, Fernando...> ;Practical Radiation Oncology. 2020 Mar 1
• 29 citations
  Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT).
  Neal D. Shore, Daniel Saltzstein, Paul Sieber, Bryan A. Mehlhaff, Lawrence Gervasi, Jennifer Phillips, Yu-Ning Wong, Huiling Pei, Tracy McGowan> ;Clinical Genitourinary Cancer. 2019 Aug 6
• 56 citations
  Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prosp...
  John L. Gore, Marguerite du Plessis, Maria Santiago-Jimenez, Kasra Yousefi, Darby J. S. Thompson, Lawrence Karsh, Brian R. Lane, Michael E. Franks, David Y.T. Chen, Ma...> ;Cancer. 2017 Aug 1
• 21 citations
  The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection...
  E. David Crawford, Daniel P. Petrylak, Neal D. Shore, Fred Saad, Susan F. Slovin, Nicholas J. Vogelzang, Thomas E. Keane, Phillip J. Koo, Leonard G. Gomella, Joe M. O'...> ;Urology. 2017 Mar 14
• 66 citations
  Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
  Alison T Stopeck, Karim Fizazi, Jean-Jacques Body, Janet E Brown, Michael Carducci, Ingo Diel, Yasuhiro Fujiwara, Miguel Martín, Alexander Paterson, Katia Tonkin, Neal...> ;Supportive Care in Cancer. 2016 Jan 1
• 37 citations
  Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate c...
  Alison Stopeck, Karim Fizazi, Jean-Jacques Body, Janet E. Brown, Michael A. Carducci, Ingo Diel, Yasuhiro Fujiwara, Miguel Martin, Alexander H.G. Paterson, Katia Tonki...> ;Supportive Care in Cancer. 2016 Jan 1
• 259 citations
  A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
  Dipen J. Parekh, Sanoj Punnen, Daniel Sjöberg, Scott Asroff, James Bailen, James S. Cochran, Raoul S. Concepcion, Richard D. David, Kenneth B. Deck, Igor Dumbadze, Mic...> ;European Urology. 2015 Sep 1
• 58 citations
  Pharmacological Inhibition of Myostatin and Changes in Lean Body Mass and Lower Extremity Muscle Size in Patients Receiving Androgen Deprivation Therapy for Prostate C...
  Desmond Padhi, Celestia S. Higano, Neal D. Shore, Paul Sieber, Erik Stavnsager Rasmussen, Matthew R. Smith> ;The Journal of Clinical Endocrinology and Metabolism. 2014 Jun 27
• 8 citations
  Emerging Therapeutic for the Treatment of Skeletal-related Events Associated With Metastatic Castrate-resistant Prostate Cancer
  Paul R Sieber> ;Reviews in Urology. 2014 Jan 1
• 73 citations
  Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer
  E. David Crawford, Nelson N. Stone, Evan Y. Yu, Phillip J. Koo, Stephen J. Freedland, Susan F. Slovin, Leonard G. Gomella, E. Roy Berger, Thomas E. Keane, Paul Sieber,...> ;Urology. 2014 Mar 1
• 170 citations
  Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen ...
  Matthew R. Smith, Fred Saad, Stéphane Oudard, Neal D. Shore, Karim Fizazi, Paul Sieber, Bertrand Tombal, Ronaldo Damião, Gavin Marx, Kurt Miller, Peter J. Van Veldhuiz...> ;Journal of Clinical Oncology. 2013 Oct 20
• 3 citations
  Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.
  Neal D. Shore, Paul Sieber, Leanne Schimke, Adam Perzin, Scott M. Olsen> ;Urologic Nursing. 2013 Sep 1
• A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.
  Paller CJ Ye X Wozniak PJ Gillespie BK Sieber PR Greengold RH Stockton BR Hertzman BL Efros MD Roper RP Liker HR Carducci MA> ;Prostate Cancer Prostatic Dis. 2013 Mar
• 42 citations
  Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene
  Samir S. Taneja, Ronald A. Morton, G. Barnette, Paul Sieber, Michael L. Hancock, Mitchell S. Steiner> ;Journal of Clinical Oncology. 2013 Feb 10
• 101 citations
  Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
  Matthew R Smith, Ronald A Morton, K Gary Barnette, Paul R Sieber, S Bruce Malkowicz, Domingo Rodriguez, Michael L Hancock, Mitchell S Steiner> ;The Journal of Urology. 2013 Jan 1
• 115 citations
  Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer
  Matthew R. Smith, Fred Saad, Blair Egerdie, Paul Sieber, Teuvo L.J. Tammela, Chunlei Ke, Benjamin Z. Leder, Carsten Goessl> ;Journal of Clinical Oncology. 2012 Sep 10
• 12 citations
  Responder Analysis of the Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
  R B Egerdie, Fred Saad, Matthew R. Smith, Teuvo L.J. Tammela, Jiri Heracek, Paul Sieber, Chunlei Ke, Benjamin Z. Leder, Roger Dansey, Carsten Goessl> ;Prostate Cancer and Prostatic Diseases. 2012 Sep 1
• 1 citations
  The role of distal third radius dual energy X-ray absorptiometry (DXA) and central DXA in evaluating for osteopenia and osteoporosis in men receiving androgen deprivat...
  Paul Sieber, F. Michael Rommel, Chris G. Theodoran, Paul J. Russinko, Christopher A. Woodward, Leanne Schimke> ;Journal of Clinical Densitometry. 2012 Jul 1
• Effect of denosumab on prolonging bone-metastasis-free survival (BMFS) in men with nonmetastatic castrate-resistant prostate cancer (CRPC) presenting with aggressive P...
  Smith MR, Saad F, Shore ND, Oudard S, Miller K, Tombal B, Sieber P, Fizazi K, Van Veldhuizen PJ, Damião R, Marx GM, Morote J, Feng A, Dansey R, Goessl CD> ;J. Clin. Oncol.. 2012-02-10
• 579 citations
  Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.
  Matthew R. Smith, Fred Saad, Robert E. Coleman, Neal D. Shore, Karim Fizazi, Bertrand Tombal, Kurt Miller, Paul Sieber, Lawrence Karsh, Ronaldo Damião, Teuvo L.J. Tamm...> ;Lancet. 2012 Jan 7
• 21 citations
  Denosumab and Changes in Bone Turnover Markers During Androgen Deprivation Therapy for Prostate Cancer
  Matthew R. Smith, Fred Saad, Blair Egerdie, Paul Sieber, Teuvo L.J. Tammela, Benjamin Z. Leder, Chunlei Ke, Carsten Goessl> ;Journal of Bone and Mineral Research. 2011 Dec 1
• Join now to see all